Cargando…
Symptoms, impacts, and suitability of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT™) questionnaire in patients with sarcoidosis-associated pulmonary hypertension (SAPH): a qualitative interview study
BACKGROUND: Sarcoidosis-associated pulmonary hypertension (SAPH) is a prevalent and serious complication of sarcoidosis. No SAPH-specific self-report instruments for assessing SAPH symptoms and their impact on patients are available to date. This study sought to determine whether the Pulmonary Arter...
Autores principales: | Currie, Brooke M., Davies, Evan W., Beaudet, Amélie, Stassek, Larissa, Kleinman, Leah, Baughman, Robert P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590341/ https://www.ncbi.nlm.nih.gov/pubmed/34772372 http://dx.doi.org/10.1186/s12890-021-01694-1 |
Ejemplares similares
-
Symptoms, impacts, and suitability of the Pulmonary Arterial Hypertension – Symptoms and Impact (PAH-SYMPACT™) questionnaire in patients with chronic thromboembolic pulmonary hypertension (CTEPH): a qualitative interview study
por: Currie, Brooke, et al.
Publicado: (2021) -
Development of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT®) questionnaire: a new patient-reported outcome instrument for PAH
por: McCollister, Deborah, et al.
Publicado: (2016) -
Symptom phenotypes in pulmonary arterial hypertension: The PAH “symptome”
por: Matura, Lea Ann, et al.
Publicado: (2022) -
Pulmonary hypertension associated with sarcoidosis
por: Baughman, Robert P
Publicado: (2007) -
Pulmonary Hypertension Associated Genetic Variants in Sarcoidosis Associated Pulmonary Hypertension
por: Groen, Karlijn, et al.
Publicado: (2022)